InsidersTradesSigma
Discover the full record of transactions filed by Haddadin Yezan Munther, Director. Director active across 1 companies, notably Outlook Therapeutics, Inc.. Aggregated, 2 reports have been published. Total volume traded: €25k. The latest transaction was filed on 2 December 2021 — Acquisition. Regulator: SEC (Form 4). The full history is accessible without signup.
2 of 2 declarations
Yezan Munther Haddadin is a Board Member at Outlook Therapeutics, Inc. As a board member, he plays a key role in the governance of the company. His experience and business acumen are essential in guiding strategic decisions and ensuring compliance with regulatory standards. He also contributes to overseeing the company's performance.